Top Recommendations from CNBC's 'Final Trades' Showcased
CNBC's Insights on Final Trades
In a recent session of CNBC's 'Final Trades', notable financial experts shared their top stock picks that are making waves in the market. The discussion centered around potential investment opportunities, giving viewers valuable insights into the current state of the financial landscape.
Joshua Brown's Focus on Rocket Companies
Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, expressed his long-term bullish stance on Rocket Companies, Inc. (NYSE: RKT). He believes that the company is well-positioned for substantial growth, especially following recent positive developments in the housing and mortgage sector.
BTIG Analyst's Commentary
BTIG analyst Eric Hagen recently initiated coverage on Rocket Companies, providing a 'Buy' rating and setting an ambitious price target at $25. This endorsement highlights the potential that investors see in Rocket, boosting market confidence as the stock continues to draw attention.
Jim Lebenthal on Cisco's Resilience
Jim Lebenthal, a partner at Cerity Partners, is recommending Cisco Systems, Inc. (NASDAQ: CSCO) despite a slight dip of around 8% following its earnings report. Cisco reported a fiscal fourth-quarter revenue of $14.67 billion, outperforming expectations, yet the stock reacted negatively. This divergence presents an interesting opportunity for investors as they assess Cisco's long-term viability in the networking equipment market.
Financial Performance Behind Cisco's Share Price
Cisco's fourth-quarter adjusted earnings were reported at 99 cents per share, surpassing analyst forecasts of 97 cents. This strong performance demonstrates the company's ability to generate consistent revenues in a competitive market, and many analysts believe that now could be an advantageous time to invest.
Liz Young Thomas Discusses iShares Tech ETF
Investment strategist Liz Young Thomas remarked on the iShares Expanded Tech-Software Sector ETF (NYSE: IGV), describing it as significantly undervalued. This ETF contains many prominent tech software companies and represents a strategic choice for investors looking to gain exposure to the technology sector.
Joe Terranova’s Selection of Insulet Corporation
Joe Terranova, senior managing director at Virtus Investment Partners, highlighted Insulet Corporation (NASDAQ: PODD) as his top trade. Insulet, known for its insulin delivery technology, has seen significant expansion lately. The firm reported a remarkable 32.9% year-over-year sales increase, signaling robust demand for its product offerings.
Market Reactions
As of the latest trading session, Rocket Companies had shares close at $18.44, marking a gain of 3.4%. Conversely, Cisco shares settled at $66.76, down by 0.3%. The iShares Tech ETF saw a decline of 2.6%, while Insulet closed at $327.48, reflecting a slight increase of 1.4%. These movements indicate the ongoing volatility in the market as investors react to various factors.
Conclusion
As CNBC's 'Final Trades' highlighted these compelling recommendations, investors are encouraged to conduct thorough research and consider these insights when evaluating their investment strategies. The diversity of picks ranging from innovative technology firms to established players in the financial sector reflects a balanced approach to capitalizing on market opportunities.
Frequently Asked Questions
What was the main focus of CNBC's 'Final Trades'?
CNBC's 'Final Trades' aimed to showcase key investment opportunities highlighted by financial experts like Joshua Brown, Jim Lebenthal, and others.
Which stock did Joshua Brown recommend?
Joshua Brown recommended Rocket Companies, Inc. (NYSE: RKT) as a strong investment opportunity for the long term.
How did Cisco perform against analyst expectations?
Cisco reported better-than-expected earnings with a revenue of $14.67 billion but faced a price drop post-earnings, surprising many in the market.
Why is the iShares Tech ETF considered undervalued?
Liz Young Thomas stated that the iShares Expanded Tech-Software Sector ETF (NYSE: IGV) is underappreciated despite holding many high-potential tech firms.
What were Insulet's sales results?
Insulet Corporation saw impressive sales growth with a 32.9% increase year over year, which indicates strong demand for their insulin delivery products.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
